Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.7299
-0.0120 (-1.62%)
At close: Oct 13, 2025, 4:00 PM EDT
0.7660
+0.0361 (4.95%)
After-hours: Oct 13, 2025, 6:25 PM EDT
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $32.60 million as of October 13, 2025. Its market cap has increased by 34.16% in one year.
Market Cap
32.60M
Enterprise Value
52.63M
1-Year Change
34.16%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from $179.38M to $32.60M, a decrease of -81.83%. That is a compound annual growth rate of -20.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 33.13M | -31.97% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | 48.54M | -27.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |